Left ventricular assist devices and their complications: A review for emergency clinicians

被引:58
作者
Long, Brit [1 ]
Robertson, Jennifer [2 ]
Koyfman, Alex [3 ]
Brady, William [4 ]
机构
[1] Brooke Army Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA
[2] Emory Univ, Dept Emergency Med, 80 Jesse Hill Jr Dr SE,Steiner Bldg,3rd Floor, Atlanta, GA 30303 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[4] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA
关键词
Ventricular assist device; Left ventricular assist device bridge; Heart failure; Pump; Controller; Driveline; VON-WILLEBRAND SYNDROME; MECHANICAL CIRCULATORY SUPPORT; HEART-FAILURE; BLOOD-PRESSURE; RISK-FACTORS; CARDIOPULMONARY-RESUSCITATION; INFECTIOUS COMPLICATIONS; MANAGEMENT; DIAGNOSIS; OUTCOMES;
D O I
10.1016/j.ajem.2019.04.050
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction End stage heart failure is associated with high mortality. However, recent developments such as the ventricular assist device (VAD) have improved patient outcomes, with left ventricular assist devices (LVAD) most commonly implanted. Objective: This narrative review evaluates LVAD epidemiology, indications, normal function and components, and the assessment and management of complications in the emergency department (ED). Discussion: The LVAD is a life-saving device in patients with severe heart failure. While first generation devices provided pulsatile flow, current LVAD devices produce continuous flow. Normal components include the pump, inflow and outflow cannulas, driveline, and external controller. Complications related to the LVAD can be divided into those that are LVAD-specific and LVAD-associated, and many of these complications can result in severe patient morbidity and mortality. LVAD-specific complications include device malfunction/failure, pump thrombosis, and suction event, while LVAD-associated complications include bleeding, cerebrovascular event, infection, right ventricular failure, dysrhythmia, and aortic regurgitation. Assessment of LVAD function, patient perfusion, and mean arterial pressure is needed upon presentation. Electrocardiogram and bedside ultrasound are key evaluations in the ED. LVAD evaluation and management require a team-based approach, and consultation with the LVAD specialist is recommended. Conclusion: Emergency clinician knowledge of LVAD function, components, and complications is integral in optimizing care of these patients. Published by Elsevier Inc.
引用
收藏
页码:1562 / 1570
页数:9
相关论文
共 96 条
  • [1] Left Ventricular Assist Device Outflow Cannula Obstruction Treated With Percutaneous Endovascular Stenting
    Abraham, Jacob
    Remick, Joshua D.
    Caulfield, Todd
    Puhlman, Mark
    Evenson, Kathryn
    Ott, Gary
    Kirker, Eric
    [J]. CIRCULATION-HEART FAILURE, 2015, 8 (01) : 229 - 230
  • [2] Neuroendovascular Interventions for Acute Ischemic Strokes in Patients Supported with Left Ventricular Assist Devices: A Single-Center Case Series and Review of the Literature
    Al-Mufti, Fawaz
    Bauerschmidt, Andrew
    Claassen, Jan
    Meyers, Philip M.
    Colombo, Paolo C.
    Willey, Joshua Z.
    [J]. WORLD NEUROSURGERY, 2016, 88 : 199 - 204
  • [3] Ventricular Assist Device Infections
    Aslam, Saima
    [J]. CARDIOLOGY CLINICS, 2018, 36 (04) : 507 - +
  • [4] Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality
    Aslam, Saima
    Xie, Rongbing
    Cowger, Jennifer
    Kirklin, James K.
    Chu, Vivian H.
    Schueler, Stephan
    de By, Theo
    Gould, Kate
    Morrissey, Orla
    Lund, Lars H.
    Martin, Stanley
    Goldstein, Daniel
    Hannan, Margaret
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (08) : 1013 - 1020
  • [5] Risk Factors and Outcomes of Fungal Ventricular-Assist Device Infections
    Aslam, Saima
    Hernandez, Maria
    Thornby, John
    Zeluff, Barry
    Darouiche, Rabih O.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (05) : 664 - 671
  • [6] Haemate® P/Humate-P® for the treatment of von Willebrand disease: considerations for use and clinical experience
    Auerswald, G.
    Kreuz, W.
    [J]. HAEMOPHILIA, 2008, 14 : 39 - 46
  • [7] Ventricular arrhythmias during left ventricular assist device support
    Bedi, Maninder
    Kormos, Robert
    Winowich, Steve
    McNamara, Dennis M.
    Mathier, Michael A.
    Murali, Srinivas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08) : 1151 - 1153
  • [8] Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000530]
  • [9] Blood pressure management in mechanical circulatory support
    Bennett, Mosi K.
    Adatya, Sirtaz
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (12) : 2125 - 2128
  • [10] Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices
    Bennett, Mosi K.
    Roberts, Celine A.
    Dordunoo, Dzifa
    Shah, Ashish
    Russell, Stuart D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (05) : 593 - 594